Aspirin May Help Prevent Mesothelioma According to New Study

A new study conducted by the University of Hawaii Cancer Center, aspirin has been shown to inhibit the growth of mesothelioma tumor cells which grow in the protective lining of the body’s internal organs affecting mostly the lungs and abdomen. The popular over-the-counter drug does this by blocking the effects of a key molecule that promotes growth in the disease.

Currently, some treatment options for mesothelioma patients include radiation, surgery, chemotherapy, acupuncture, holistic medicine, and changes in diet and nutrition.

Though clinical trials are in the beginning stages, researchers believe that aspirin may be a good option in terms of prevention for those who are at high risk of developing mesothelioma.

According to the website of the mesothelioma attorneys at Williams Kherkher, workers with the following careers have been shown to be at an increased risk of developing mesothelioma through asbestos exposure: construction workers, building contractors, factory employees, military personnel, and railroad workers.

Though it may have some minor effects, aspirin has been shown to not be as effective during the later stages of mesothelioma development. However, in the early stages, the medication has been shown to increase survival from 76.5 days to 96 days. More surprisingly, the study found a 30 percent reduction in mesothelioma contraction risk.

The study also tested a drug known as BoxA. The drug is an experimental medication that imitates the effects of aspirin on mesothelioma tumors. While the drug increased survival time to 142 days from aspirin’s 96 days, the drug was shown to have some side effects.

Researchers hope that further testing will provide them with further analyses in order to fine tune the experimental drug. Until then, they highly recommend aspirin for those that believe they may be at risk.

read more